Treatment Characteristics of Chronic Low Back Pain Patients Treated with Buprenorphine Buccal Film or Transdermal Patch

References

• Shmagel A , Foley R , Ibrahim H . Epidemiology of chronic low back pain in US adults: data from the 2009–2010 National Health and Nutrition Examination Survey. Arthritis Care Res. 68(11), 1688–1694 (2016).
   PubMed Web of Science ®Google Scholar
• Manchikanti L , Singh V , Falco FJE , Benyamin RM , Hirsch JA . Epidemiology of low back pain in adults. Neuromodulation 17(Suppl. 2), 3–10 (2014).
   PubMed Web of Science ®Google Scholar
• Dahlhamer J , Lucas J , Zelaya C et al. Prevalence of chronic pain and high-impact chronic pain among adults – United States, 2016. MMWR Morb. Mortal. Wkly Rep. 67(36), 1001–1006 (2018).
   PubMed Web of Science ®Google Scholar
• Stevans JM , Delitto A , Khoja SS et al. Risk factors associated with transition from acute to chronic low back pain in US patients seeking primary care. JAMA Netw. Open. 4(2), e2037371 (2021).
   PubMed Web of Science ®Google Scholar
• Kim LH , Vail D , Azad TD et al. Expenditures and health care utilization among adults with newly diagnosed low back and lower extremity pain. JAMA Netw. Open. 2(5), e193676 (2019).
   PubMed Web of Science ®Google Scholar
• Qaseem A , Wilt TJ , Mclean RM et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 166(7), 514–530 (2017).
   PubMed Web of Science ®Google Scholar
• North American Spine Society (NASS) . Evidence-based clinical guidelines for multidisciplinary spine care: diagnosis and treatment of low back pain 2020). (Accessed May 2023). www.spine.org/Portals/0/assets/downloads/ResearchClinicalCare/Guidelines/LowBackPain.pdf
   Google Scholar
• Department of Veteran Affairs (VA) and Department of Defense (DoD) . VA/DoD clinical practice guideline for the diagnosis and treatment of low back pain v3.0 (2022). (Accessed May 2023). www.healthquality.va.gov/guidelines/pain/lbp/
   Google Scholar
• Dowell D , Ragan KR , Jones CM , Baldwin GT , Chou R . CDC clinical practice guideline for prescribing opioids for pain – United States, 2022. MMWR Recomm. Rep. 71(3), 1–95 (2022).
   PubMed Web of Science ®Google Scholar
• Dowell D , Haegerich TM , Chou R . CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm. Rep. 65(1), 1–49 (2016).
   PubMed Web of Science ®Google Scholar
• Fine PG , Mahajan G , Mcpherson ML . Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain Med. 10(Suppl. 2), S79–S88 (2009).
   PubMedGoogle Scholar
• Shmagel A , Ngo L , Ensrud K , Foley R . Prescription medication use among community-based US adults with chronic low back pain: a cross-sectional population based study. J. Pain 19(10), 1104–1112 (2018).
   PubMed Web of Science ®Google Scholar
• White AP , Arnold PM , Norvell DC , Ecker E , Fehlings MG . Pharmacologic management of chronic low back pain: synthesis of the evidence. Spine 36(Suppl. 21), S131–S143 (2011).
   PubMed Web of Science ®Google Scholar
• Webster L , Gudin J , Raffa RB et al. Understanding buprenorphine for use in chronic pain: expert opinion. Pain Med. 21(4), 714–723 (2020).
   PubMed Web of Science ®Google Scholar
• Elkader A , Sproule B . Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin. Pharmacokinet. 44(7), 661–680 (2005).
   PubMed Web of Science ®Google Scholar
• STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) Statement Checklist (2023). (Accessed 13 November 2023 ). www.strobe-statement.org/
   Google Scholar
• Merative . Merative™ MarketScan® Research Databases (2023). (Accessed 15 April 2023 ). www.merative.com/real-world-evidence
   Google Scholar
• The University of Utah . Opioid oral morphine milligram equivalent (MME) conversion factors (2022). (Accessed 15 April 2023 ). https://medicaid.utah.gov/Documents/files/Opioid-Morphine-EQ-Conversion-Factors.pdf
   Google Scholar
• IBM Corporation . IBM SPSS Statistics (2023). (Accessed 13 November 2023 ). www.ibm.com/products/spss-statistics
   Google Scholar
• Abdel Shaheed C , Maher CG , Williams KA , Day R , Mclachlan AJ . Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern. Med. 176(7), 958–968 (2016).
   PubMed Web of Science ®Google Scholar
• Altman RD , Smith HS . Opioid therapy for osteoarthritis and chronic low back pain. Postgrad. Med. 122(6), 87–97 (2010).
   PubMed Web of Science ®Google Scholar
• Cashin AG , Wand BM , O’Connell NE et al. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst. Rev. 4(4), Cd013815 (2023).
   PubMedGoogle Scholar
• Chou R , Turner JA , Devine EB et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention workshop. Ann. Intern. Med. 162(4), 276–286 (2015).
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMSHA) – Center for Behavioral Health Statistics and Quality . Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health (2021). (Accessed 20 April 2023 ). www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf
   Google Scholar
• Gordon A , Rashiq S , Moulin DE et al. Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. Pain Res. Manag. 15(3), 169–178 (2010).
   PubMed Web of Science ®Google Scholar
• Steiner D , Munera C , Hale M , Ripa S , Landau C . Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study. J. Pain 12(11), 1163–1173 (2011).
   PubMed Web of Science ®Google Scholar
• Miller K , Yarlas A , Wen W et al. Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain. Expert Opin. Pharmacother. 14(3), 269–277 (2013).
   PubMed Web of Science ®Google Scholar
• Rauck RL , Potts J , Xiang Q , Tzanis E , Finn A . Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgrad. Med. 128(1), 1–11 (2016).
   PubMed Web of Science ®Google Scholar
• Pergolizzi JV Jr , Raffa RB . Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. J. Pain Res. 12, 3299–3317 (2019).
   PubMed Web of Science ®Google Scholar